Cargando…

Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?

BACKGROUND: Diagnosing systemic juvenile idiopathic arthritis (SJIA) can be extremely challenging if typical arthritis is lacking. A variety of biomarkers have been described for the diagnosis and management of SJIA. However, very few markers have been well-validated. In addition, increasing numbers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gohar, Faekah, Kessel, Christoph, Lavric, Miha, Holzinger, Dirk, Foell, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944486/ https://www.ncbi.nlm.nih.gov/pubmed/27411444 http://dx.doi.org/10.1186/s13075-016-1069-z

Ejemplares similares

Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study
por: Tappeiner, Christoph, et al.
Publicado: (2018)

Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study
por: Heiligenhaus, Arnd, et al.
Publicado: (2019)

Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial
por: Gerss, Joachim, et al.
Publicado: (2022)

MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis
por: Anink, Janneke, et al.
Publicado: (2015)

The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases
por: Holzinger, Dirk, et al.
Publicado: (2018)

PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis
por: Lavric, M, et al.
Publicado: (2013)

Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) Show Differences in Autoantibody Signatures Based on Disease Activity
por: Krainer, Julie, et al.
Publicado: (2023)

A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
por: Foell, Dirk, et al.
Publicado: (2023)

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort
por: Kirchner, Sabine, et al.
Publicado: (2023)

Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis
por: Sumner, Emma J., et al.
Publicado: (2022)

Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany
por: Hinze, Claas H., et al.
Publicado: (2018)

Serum biomarkers confirming stable remission in inflammatory bowel disease
por: Kessel, Christoph, et al.
Publicado: (2021)

Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA
por: Schulz, Caroline, et al.
Publicado: (2022)

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort
por: Sengler, Claudia, et al.
Publicado: (2018)

The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Holzinger, Dirk, et al.
Publicado: (2018)

PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
por: Anink, J, et al.
Publicado: (2013)

Comics as an educational tool for children with juvenile idiopathic arthritis
por: Mendelson, Amir, et al.
Publicado: (2017)

PReS-FINAL-2068: S100 A8/A9 serum levels reflect disease activity in juvenile idiopathic arthritis-associated uveitis
por: Walscheid, K, et al.
Publicado: (2013)

No association of IL-12p40 pro1.1 polymorphism with juvenile idiopathic arthritis
por: Eberhardt, Christiane S., et al.
Publicado: (2015)

Juvenile idiopathic arthritis
por: Bhatt, Krupa H, et al.
Publicado: (2014)

Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
por: Ombrello, Michael J, et al.
Publicado: (2017)

Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long‐Term Safety Data from the German BIKER Registry
por: Klein, Ariane, et al.
Publicado: (2019)

PReS-FINAL-2150: Antiocular antibodies in children with juvenile idiopathic arthritis-associated uveitis
por: Walscheid, K, et al.
Publicado: (2013)

Application of systems biology-based in silico tools to optimize treatment strategy identification in Still’s disease
por: Segú-Vergés, Cristina, et al.
Publicado: (2021)

Atherosclerosis in Juvenile Idiopathic Arthritis
por: Jednacz, Ewa, et al.
Publicado: (2012)

Juvenile idiopathic arthritis classification
por: Martini, Alberto
Publicado: (2014)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

The joints in juvenile idiopathic arthritis
por: Ording Muller, Lil-Sofie, et al.
Publicado: (2015)

Ultrasound in juvenile idiopathic arthritis
por: Magni-Manzoni, Silvia
Publicado: (2016)

Haptoglobin in Juvenile Idiopathic Arthritis
por: Berntson, Lillemor, et al.
Publicado: (2022)

Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
por: Van Dijkhuizen, Pieter, et al.
Publicado: (2014)

Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?
por: Prahalad, Sampath, et al.
Publicado: (2002)

Internationalization - tips and tricks
por: Hoffmann, Dirk
Publicado: (2017)

P16 Using virtual reality to help manage needle phobia in juvenile idiopathic arthritis
por: McCarthy, Sarah, et al.
Publicado: (2021)

Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry
por: Lainka, Elke, et al.
Publicado: (2021)

When kinetics plays strange tricks
por: Laio, Alessandro
Publicado: (2022)

The TLR4 ligands MRP8 and MRP14 in the diagnosis and pathogenesis of systemic onset juvenile idiopathic arthritis
por: Frosch, M, et al.
Publicado: (2008)

Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study
por: ter Haar, Nienke M., et al.
Publicado: (2019)

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
por: Swart, Joost F, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ld8qme9d8dqh5lhn912rjjmeip